BARFRESH FOOD GROUP INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BARFRESH FOOD GROUP INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Mar 31, 2015 | $211.5K | Jul 7, 2015 |
| FY2015 | Mar 31, 2014 | $110.1K | Jul 7, 2015 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.21M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $10.72M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $8.13M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $9.16M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $6.70M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $2.57M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $4.31M | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | $4.24M | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | $2.00M | Apr 1, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.00M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $1.46M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $437.3K | Mar 30, 2017 |
| FY2015 | Mar 31, 2015 | $211.5K | Jul 7, 2015 |
| FY2015 | Mar 31, 2014 | $110.1K | Jul 7, 2015 |
| FY2014 | Mar 31, 2013 | $8.9K | Jun 30, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.11M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $3.67M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $2.88M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.44M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.51M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $764.1K | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $2.31M | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | $2.14M | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | $889.7K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $684.7K | Apr 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.69M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($2.83M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($2.82M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($6.13M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($1.27M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($4.15M) | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | ($5.59M) | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | ($7.32M) | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | ($8.91M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($10.19M) | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.43M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($2.77M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($2.82M) | Mar 27, 2025 |
| FY2022 | Dec 31, 2022 | ($6.22M) | Mar 2, 2023 |
| FY2022 | Dec 31, 2021 | ($2.10M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($4.21M) | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | ($5.19M) | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | ($6.18M) | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | ($8.91M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($9.94M) | Apr 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $128.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $132.0K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $115.0K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $382.0K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $245.0K | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $515.1K | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $538.4K | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | $674.2K | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | $575.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $432.1K | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.67M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($2.23M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($2.94M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($2.65M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($1.86M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($3.27M) | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | ($3.35M) | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | ($4.13M) | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | ($7.33M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($8.02M) | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $53.0K | Apr 15, 2026 |
| FY2023 | Dec 31, 2022 | $13.0K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $151.0K | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $59.7K | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $466.2K | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | $1.11M | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | $535.2K | Apr 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.83M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $3.32M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $4.81M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $5.51M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $9.72M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $5.82M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $5.13M | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | $5.76M | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | $5.43M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $11.82M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.50M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $2.74M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $2.31M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.57M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.54M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $3.49M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $4.84M | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | $5.80M | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | $1.27M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $913.1K | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.33M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $578.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | $2.50M | Apr 15, 2026 |
| FY2024 | Dec 31, 2022 | $2.93M | Mar 27, 2025 |
| FY2023 | Dec 31, 2021 | $8.50M | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $2.32M | Mar 2, 2023 |
| FY2021 | Dec 31, 2019 | $283.7K | Mar 10, 2022 |
| FY2020 | Dec 31, 2018 | ($35.0K) | Apr 14, 2021 |
| FY2019 | Dec 31, 2017 | $4.16M | Apr 13, 2020 |
| FY2018 | Dec 31, 2016 | $10.91M | Apr 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($66.32M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($63.62M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($60.80M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($57.97M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($52.17M) | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | ($50.90M) | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | ($46.75M) | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | ($41.15M) | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | ($33.83M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($24.92M) | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $2.81M | Mar 2, 2023 |
| FY2022 | Dec 31, 2021 | $5.53M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | $1.82M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | $1,000.0K | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | $1.04M | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | $1.30M | Apr 1, 2019 |
| FY2018 | Dec 31, 2016 | $9.18M | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $1.99M | Apr 2, 2018 |
| FY2016 | Mar 31, 2015 | $5.36M | Mar 30, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $766.0K | Apr 15, 2026 |
| FY2024 | Dec 31, 2024 | $223.0K | Mar 27, 2025 |
| FY2020 | Dec 31, 2020 | $1.14M | Apr 14, 2021 |
| FY2019 | Dec 31, 2019 | $1.42M | Apr 13, 2020 |
| FY2018 | Dec 31, 2018 | $3.62M | Apr 1, 2019 |
| FY2016 | Dec 31, 2016 | $12.8K | Mar 30, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 2, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 22, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.97M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 14.75M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 14.42M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 12.93M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 12.91M | Mar 2, 2023 |
| FY2021 | Dec 31, 2020 | 11.47M | Mar 10, 2022 |
| FY2020 | Dec 31, 2019 | 130.34M | Apr 14, 2021 |
| FY2019 | Dec 31, 2018 | 122.77M | Apr 13, 2020 |
| FY2018 | Dec 31, 2017 | 118.69M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 117.10M | Apr 2, 2018 |